1. Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients
- Author
-
Myung Hwan Bae, Jongmin Hwang, Yongkeun Cho, Byung Chun Jung, Seongwook Han, Chan Hee Lee, Hyoung Seob Park, Young Soo Lee, Jinhee Ahn, Jong Sung Park, Ki-Hun Kim, Dong Gu Shin, Dae Woo Hyun, and Hyun Jun Cho
- Subjects
Male ,Tachycardia ,medicine.medical_specialty ,Heart Ventricles ,Cardiovascular Disorders ,medicine.medical_treatment ,Kaplan-Meier Estimate ,Risk Assessment ,Electrocardiography ,Ventricular Dysfunction, Left ,03 medical and health sciences ,0302 clinical medicine ,Implantable Cardioverter-Defibrillator ,Risk Factors ,Internal medicine ,Natriuretic Peptide, Brain ,Republic of Korea ,medicine ,Humans ,Registries ,030212 general & internal medicine ,Aged ,Proportional Hazards Models ,Framingham Risk Score ,business.industry ,Mortality rate ,General Medicine ,Middle Aged ,medicine.disease ,Implantable cardioverter-defibrillator ,Peptide Fragments ,Defibrillators, Implantable ,Primary Prevention ,Death, Sudden, Cardiac ,Treatment Outcome ,Shock (circulatory) ,Heart failure ,Ventricular fibrillation ,Female ,Original Article ,medicine.symptom ,Cardiomyopathies ,business ,Body mass index ,Follow-Up Studies - Abstract
Background Studies on the efficacy of implantable cardioverter-defibrillator (ICD) therapy for primary prevention in Asian patients are relatively lacking compared to those for secondary prevention. Also, it is important to stratify which patients will benefit from ICD therapy for primary prevention. Methods Of 483 consecutive patients who received new implantation of ICD in 9 centers in Korea, 305 patients with reduced left ventricular systolic function and/or documented ventricular fibrillation/tachycardia were enrolled and divided into primary (n = 167) and secondary prevention groups (n = 138). Results During mean follow-up duration of 2.6 ± 1.6 years, appropriate ICD therapy occurred in 78 patients (25.6%), and appropriate ICD shock and anti-tachycardia pacing occurred in 15.1% and 15.1% of patients, respectively. Appropriate ICD shock rate was not different between the two groups (primary 12% vs. secondary 18.8%, P = 0.118). However, appropriate ICD therapy rate including shock and anti-tachycardia pacing was significantly higher (primary 18% vs. secondary 34.8%, P = 0.001) in the secondary prevention group. Type of prevention and etiology, appropriate and inappropriate ICD shock did not affect all-cause death. High levels of N-terminal pro-B-type natriuretic peptide, New York Heart Association functional class, low levels of estimated glomerular filtration ratio, and body mass index were associated with death before appropriate ICD shock in the primary prevention group. When patients were categorized in 5 risk score groups according to the sum of values defined by each cut-off level, significant differences in death rate before appropriate ICD shock were observed among risk 0 (0%), 1 (3.6%), 2 (3%), 3 (26.5%), and 4 (40%) (P < 0.001). Conclusion In this multicenter regional registry, the frequency of appropriate ICD therapy is not low in the primary prevention group. In addition, combination of poor prognostic factors of heart failure is useful in risk stratification of patients who are not benefiting from ICD therapy for primary prevention., Graphical Abstract
- Published
- 2020